| product_name | (2E)-3-{6-[(1E)-1-(4-Methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid |
| CAS_number | 352665-43-1 |
| formula | C19H20N2O2 |
| molar_mass | 308.38 |
| melting_point | Not specified |
| boiling_point | Not specified |
| density | Not specified |
| solubility | Not specified |
| appearance | Not specified |
| specific_rotation | Not specified |
| flash_point | Not specified |
| refractive_index | Not specified |
| pKa | Not specified |
| logP | Not specified |
What is the chemical composition of (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid?
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid is a compound with a complex molecular structure that contains various elements such as carbon, hydrogen, nitrogen, and oxygen. This compound belongs to the class of acrylic acids and is known for its potential biological activities.
What are the potential pharmaceutical applications of (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid?
(2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid has shown promise in various pharmaceutical applications due to its structural features and interactions with biological targets. Studies have demonstrated its potential use in drug development for conditions such as cancer, inflammation, and neurological disorders.
How does (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid interact with biological systems?
The interaction of (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid with biological systems involves binding to specific receptors or enzymes, leading to various downstream effects. These interactions can modulate cellular signaling pathways, gene expression, and protein function, ultimately influencing physiological processes.
What are the mechanisms of action of (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid?
The mechanisms of action of (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid involve its ability to interact with specific molecular targets in biological systems. This compound can exhibit inhibitory or stimulatory effects on enzymes, receptors, or other proteins, leading to alterations in cellular processes and physiological functions.
How is the bioavailability of (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid optimized for therapeutic use?
The bioavailability of (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid can be optimized through various formulations and delivery methods. Strategies such as encapsulation, prodrug modifications, and targeted delivery systems can enhance the absorption, distribution, and stability of the compound in biological systems, improving its therapeutic efficacy.
What are the potential side effects or adverse reactions associated with (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid?
Like any pharmaceutical compound, (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid may have potential side effects or adverse reactions. Common adverse effects may include gastrointestinal disturbances, allergic reactions, or changes in laboratory parameters. It is important to monitor patients closely during treatment and adjust dosages accordingly.
What preclinical or clinical studies have been conducted on (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid?
Several preclinical and clinical studies have been conducted to investigate the pharmacological properties and potential therapeutic applications of (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid. These studies have explored the compound's efficacy, safety profile, and mechanisms of action in various disease models or patient populations, providing valuable insights for future development.
What are the future prospects for the use of (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid in medicine?
The future prospects for the use of (2E)-3-{6-[(1E)-1-(4-methylphenyl)-3-(1-pyrrolidinyl)-1-propen-1-yl]-2-pyridinyl}acrylic acid in medicine are promising, given its potential as a novel therapeutic agent for various diseases. Ongoing research and development efforts aim to further elucidate its biological activities, optimize its pharmacokinetic properties, and advance its clinical applications, highlighting the compound's role in future healthcare innovations.